Nanonucleant, a spin-out of Imperial College London, is seeking angel financing to move ahead with a glass grain-based technology that aids in crystallising proteins for study as drug targets.
This device delivers large molecules directly into cells, and even into specific sites within cells, whilst avoiding the cellular damage associated with other drug delivery methods.
The official Irish government report on the failed Media Lab Europe project has focused attention another industry-academic research partnerships – one involving Bell Labs and a consortium of eight Irish universities.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.